NICE limits treatment choice for rheumatoid arthritis.
Adam
David
D
D000047:Academies and Institutes / Q000458:organization & administration; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000453:epidemiology; D004335:Drug and Narcotic Control / Q000458:organization & administration*; D004739:England / Q000453:epidemiology; D006291:Health Policy; D006801:Humans; D018579:Patient Selection; D011785:Quality Assurance, Health Care / Q000458:organization & administration; D013222:State Medicine / Q000458:organization & administration*; D016896:Treatment Outcome; D000079424:Tumor Necrosis Factor Inhibitors; D014852:Wales / Q000453:epidemiology
D018501:Antirheumatic Agents; D000079424:Tumor Necrosis Factor Inhibitors